Nexus Uranium raises $1.75 million

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES

THE PROSPECTUS SUPPLEMENT, THE CORRESPONDING SHELF PROSPECTUS AND ANY AMENDMENT TO THE DOCUMENTS ARE ACCESSIBLE THROUGH SEDAR+, OR WILL BE ACCESSIBLE THROUGH SEDAR+ WITHIN 2 BUSINESS DAYS, AS APPLICABLE

Vancouver, British Columbia--(Newsfile Corp. - September 10, 2026) - Nexus Uranium Corp. (CSE: NEXU) (OTCQB: NEXUF) (FSE: JA7) (" Nexus " or the " Company ") is pleased to announce a non-brokered prospectus financing of units (the " Units ") consisting of up to 3,125,000 Units at $0.56 per Unit for gross proceeds of up to $1,750,000 (the " Offering "). Each Unit will be comprised of one common share of the Company (a " Common Share ") and one Common Share purchase warrant of the Company (a " Warrant "). Each Warrant will entitle the holder to acquire one Common Share (a " Warrant Share ") at an exercise price of $0.70 per Warrant Share for a period of 18 months from closing of the Offering.

The Offering will be subscribed by 'accredited investors' under applicable securities laws, and the Company will be entering into formal subscription agreements with each investor to purchase the Units.

The Company may pay finders' fees. The Company intends to use the proceeds from the Offering to advance the Company's uranium property portfolio in South Dakota and Arizona, and for general working capital and corporate purposes.

The Units will be qualified under a shelf prospectus supplement (the " Prospectus Supplement ") to be filed with the securities commissions in each of the provinces and territories of Canada, prior to closing and in accordance with National Instrument 44-101 Short Form Prospectus Distributions and National Instrument 44-102 Shelf Distributions . The Offering will be made only by means of the Prospectus Supplement and the corresponding base shelf prospectus dated February 3, 2026 (the " Shelf Prospectus "). Complete details of the Offering will be set out in the Prospectus Supplement.

The Offering is expected to close on or about September 24, 2026 and is subject to certain conditions including, but not limited to, the receipt of all necessary approvals and listings, including fulfilling applicable requirements of the CSE.

The Offering is being made in each of the provinces and territories of Canada, except Quebec. Access to the Prospectus Supplement, the corresponding Shelf Prospectus and any amendment to such documents is provided in accordance with securities legislation relating to the procedures for providing access to a shelf prospectus supplement, a base shelf prospectus and any amendment. The Shelf Prospectus is, and the Prospectus Supplement will be (within two business days from the date hereof), accessible on SEDAR+ at www.sedarplus.ca . An electronic or paper copy of the Prospectus Supplement, the corresponding Shelf Prospectus, and any amendment to such documents may be obtained, without charge, from the Company by mail at 503 - 605 West Pender Street, Vancouver, BC, V6C 1L6, by telephone at (604) 722-9842, or by email at info@nexusuranium.com , by providing the contact with an email address or address, as applicable.